Compare PTGX & SPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTGX | SPT |
|---|---|---|
| Founded | 2006 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 633.9M |
| IPO Year | 2016 | 2019 |
| Metric | PTGX | SPT |
|---|---|---|
| Price | $86.61 | $10.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $90.56 | $26.00 |
| AVG Volume (30 Days) | 932.2K | ★ 987.2K |
| Earning Date | 02-20-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | $209,217,000.00 | ★ $443,750,000.00 |
| Revenue This Year | N/A | $13.30 |
| Revenue Next Year | $288.98 | $11.37 |
| P/E Ratio | $121.05 | ★ N/A |
| Revenue Growth | N/A | ★ 13.09 |
| 52 Week Low | $33.70 | $9.16 |
| 52 Week High | $96.54 | $35.18 |
| Indicator | PTGX | SPT |
|---|---|---|
| Relative Strength Index (RSI) | 46.55 | 42.24 |
| Support Level | $84.11 | $10.97 |
| Resistance Level | $89.61 | $11.63 |
| Average True Range (ATR) | 3.03 | 0.48 |
| MACD | -0.73 | -0.04 |
| Stochastic Oscillator | 17.10 | 5.98 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions.